Tekla Life Sciences Investors (HQL) P/E Ratio History
Fairly ValuedTrading at 6.5x, near 5Y avg of 7.0x · 70th percentile · In line with own history · Data 1998–2026
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Tekla Life Sciences Investors (HQL) trades at a price-to-earnings ratio of 6.5x, with a stock price of $19.25 and trailing twelve-month earnings per share of $4.59.
The current P/E is roughly in line with its 5-year average of 7.0x. Over the past five years, HQL's P/E has ranged from a low of 2.0x to a high of 41.6x, placing the current valuation at the 70th percentile of its historical range.
Compared to the Financial Services sector median P/E of 14.2x, HQL trades at a 54% discount to its sector peers. The sector includes 801 companies with P/E ratios ranging from 0.0x to 157.7x.
Relative to the broader market, HQL trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HQL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HQL Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
HQL P/E vs Peers
Closed-end funds and investment trusts peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 6.1Lowest | - | +211% | |
| $5B | 17.5 | 6.42 | -59% | |
| $11B | 32.8 | - | -19% | |
| $193B | 25.2 | 8.56 | +88% | |
| $159B | 18.9 | 0.14Best | +1684%Best | |
| $66B | 15.3 | 2.41 | +8% | |
| $125B | 32.1 | 3.87 | +837% | |
| $32B | 24.5 | - | -21% | |
| $27B | 32.4 | 7.66 | +171% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
HQL Historical P/E Data (1998–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $16.27 | $4.68 | 3.5x | -48% |
| FY2025 Q4 | - | $15.51 | $3.82 | 4.1x | -39% |
| FY2022 Q2 | - | $16.54 | $3.52 | 4.7x | -29% |
| FY2021 Q4 | - | $20.80 | $7.84 | 2.7x | -60% |
| FY2021 Q2 | Mar 31 2021 | $19.71 | $5.17 | 3.8x | -43% |
| FY2020 Q4 | Sep 30 2020 | $17.58 | $2.15 | 8.2x | +23% |
| FY2020 Q2 | - | $14.98 | $0.36 | 41.6x | +524% |
| FY2019 Q2 | Mar 31 2019 | $17.13 | $1.44 | 11.9x | +79% |
| FY2018 Q4 | Sep 30 2018 | $20.42 | $4.42 | 4.6x | -31% |
| FY2018 Q2 | Mar 31 2018 | $19.22 | $5.06 | 3.8x | -43% |
| FY2017 Q4 | Sep 30 2017 | $21.48 | $2.52 | 8.5x | +28% |
| FY2016 Q4 | Sep 30 2016 | $18.73 | $1.48 | 12.7x | +90% |
| FY2016 Q2 | - | $17.94 | $1.54 | 11.6x | +75% |
| FY2015 Q4 | Sep 30 2015 | $22.51 | $7.30 | 3.1x | -54% |
| FY2015 Q2 | - | $27.57 | $13.78 | 2.0x | -70% |
| FY2014 Q4 | - | $22.10 | $9.94 | 2.2x | -67% |
| FY2014 Q2 | Mar 31 2014 | $21.75 | $8.72 | 2.5x | -63% |
| FY2013 Q4 | Sep 30 2013 | $19.25 | $7.69 | 2.5x | -62% |
| FY2013 Q2 | Mar 31 2013 | $17.44 | $5.06 | 3.4x | -48% |
| FY2012 Q4 | Sep 30 2012 | $15.39 | $4.42 | 3.5x | -48% |
| FY2011 Q4 | Sep 30 2011 | $10.46 | $3.06 | 3.4x | -49% |
| FY2011 Q2 | Mar 30 2011 | $12.04 | $1.28 | 9.4x | +41% |
| FY2010 Q2 | - | $10.33 | $0.69 | 15.0x | +125% |
| FY2009 Q4 | Sep 30 2009 | $9.23 | $1.88 | 4.9x | -26% |
| FY2009 Q2 | Mar 30 2009 | $7.60 | $3.63 | 2.1x | -69% |
| FY2008 Q4 | - | $10.62 | $5.38 | 2.0x | -70% |
| FY2008 Q2 | Mar 30 2008 | $11.73 | $3.39 | 3.5x | -48% |
| FY2007 Q4 | Sep 30 2007 | $13.53 | $1.40 | 9.7x | +45% |
| FY2007 Q2 | Mar 30 2007 | $13.90 | $1.92 | 7.2x | +9% |
| FY2006 Q4 | Sep 30 2006 | $13.29 | $2.44 | 5.4x | -18% |
| FY2006 Q2 | - | $17.05 | $3.30 | 5.2x | -22% |
| FY2005 Q4 | Sep 30 2005 | $16.85 | $4.16 | 4.1x | -39% |
| FY2005 Q2 | Mar 30 2005 | $14.47 | $4.07 | 3.6x | -47% |
| FY2004 Q4 | - | $16.20 | $3.98 | 4.1x | -39% |
| FY2004 Q2 | - | $16.80 | $1.26 | 13.3x | +100% |
| FY1998 Q4 | Sep 30 1998 | $10.88 | $1.73 | 6.3x | -6% |
Average P/E for displayed period: 6.7x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HQL — Frequently Asked Questions
Quick answers to the most common questions about buying HQL stock.
What is HQL's P/E ratio?
Tekla Life Sciences Investors (HQL) trailing twelve-month P/E ratio is 6.5x, based on TTM diluted EPS of $4.59. The 5-year average P/E is 7.0x and the historical range spans 2.0x to 41.6x.
Is HQL stock overvalued or undervalued?
HQL trades at 6.5x P/E, near its 5-year average of 7.0x. The 70th percentile ranking within the 2.0x–41.6x historical range places valuation within normal bounds.
Is HQL stock expensive?
HQL is fairly valued relative to its own history. The current P/E of 6.5x is near the 5-year average of 7.0x (70th percentile of historical range).
What is HQL's historical P/E range?
Over the past 5 years, HQL's P/E ratio has ranged from 2.0x to 41.6x, with a median of 3.8x and an average of 7.0x. The current P/E of 6.5x places the stock at the 70th percentile of this range. Full historical data spans 1998–2026.
How does HQL's P/E compare to the S&P 500?
HQL trades at 6.5x P/E versus the S&P 500 median of 25.3x. The 74% discount to the market suggests lower growth expectations or perceived higher risk.
How does HQL's valuation compare to Financial Services peers?
Tekla Life Sciences Investors P/E of 6.5x compares to the Financial Services sector median of 14.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is HQL's PEG ratio?
HQL PEG ratio is N/A, based on a P/E of 6.5x and EPS growth of 274.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is HQL's earnings yield?
HQL earnings yield is 15.38%, the inverse of its 6.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.